Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
21.73
+0.41 (1.92%)
At close: May 22, 2026, 4:00 PM EDT
21.71
-0.02 (-0.09%)
After-hours: May 22, 2026, 7:59 PM EDT
Elanco Animal Health Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Elanco Animal Health stock has a consensus rating of "Strong Buy" and an average price target of $29.79. The average 1-year stock price forecast is 37.09% higher than the current stock price, while the lowest is $23 (+5.84%) and the highest is $32 (+47.26%).
Price Target: $29.79 (+37.09%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 6 | 7 | 7 | 7 | 6 | 6 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $30 → $31 | Strong Buy | Maintains | $30 → $31 | +42.66% | May 7, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $28 → $30 | Buy | Maintains | $28 → $30 | +38.06% | May 7, 2026 |
| Citigroup | Citigroup | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +38.06% | Apr 15, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $22 → $24 | Hold | Maintains | $22 → $24 | +10.45% | Feb 25, 2026 |
| Keybanc | Keybanc | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | +33.46% | Feb 25, 2026 |
Financial Forecast
Revenue This Year
5.16B
from 4.72B
Increased by 9.35%
Revenue Next Year
5.43B
from 5.16B
Increased by 5.24%
EPS This Year
1.11
from -0.47
EPS Next Year
1.25
from 1.11
Increased by 12.70%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5.3B | 5.7B | ||||||
| Avg | 5.2B | 5.4B | ||||||
| Low | 4.9B | 5.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 13.2% | 9.7% | ||||||
| Avg | 9.4% | 5.2% | ||||||
| Low | 3.3% | -0.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.52 | 1.69 | ||||||
| Avg | 1.11 | 1.25 | ||||||
| Low | 1.00 | 1.12 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 52.2% | ||||||
| Avg | - | 12.7% | ||||||
| Low | - | 0.6% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.